Health Care

Incyte Corp said it would discontinue some of the trials testing its already approved blood cancer drug, Jakafi, after the treatment's effectiveness was found to be insufficient.

AstraZeneca warned that revenue and earnings would drop this year due to the arrival of cheap generic rivals to its cholesterol fighter Crestor.

Theranos Inc.'s main retail partner is suspending some ties to the blood-testing laboratory in the wake of a critical regulatory inspection report.

Bristol-Myers Squibb forecast 2016 earnings slightly above Wall Street estimates.

Pfizer Inc and Allergan Plc are considering combining, the Wall Street Journal said on Wednesday.

Amgen Inc. raised its 2015 guidance as the biotechnology company reported that its third-quarter earnings rose 50% on stronger revenue led by Enbrel and other key drugs.

Gilead Sciences Inc said on Tuesday its quarterly net profit rose 32 percent, driven by sales of hepatitis C drugs that beat Wall Street estimates.

Celgene Corp. has reached a deal to buy fellow biopharmaceutical company Receptos Inc. for about $7.2 billion, enhancing its portfolio of immune-inflammatory disease treatments with the addition of Ozanimod.

A massive earthquake in Nepal has exposed the woeful state of its medical facilities as hospitals struggle to treat vast numbers of injured with limited supplies and staff.

Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday.

30 cancer patients are currently using wearable technology to ease cancer treatments.

The Zika virus is becoming more commonplace in the U.S. and experts say the South will feel the impact the most.

Valeant Pharmaceuticals is planning to appoint a new chief executive while its CEO remains under hospital care, said people familiar with the matter.

William Ackman's Pershing Square Capital Management LP trimmed its stake in Valeant Pharmaceuticals International Inc. to 8.5%, a move the hedge fund said was related to year-end tax planning.

KaloBios Pharmaceuticals Inc said on Wednesday that it had been notified by Nasdaq that its stock would be delisted using the exchange operator's "discretionary" authority.

Pfizer Inc. said its board has raised the pharmaceutical company's quarterly dividend by 7.1%.

Safety of cryotherapy questioned.

Shares of Valeant Pharmaceuticals Inc. fell further on Thursday after CVS Health Corp and Express Scripts dropped Philidor Rx from their networks.

Expecting moms will soon be able to listen to their baby’s heart rate with using their Apple Watch.

Democratic presidential candidate Hillary Clinton unveiled a plan on Wednesday to lower out-of-pocket health costs, including expanded coverage of sick visits to the doctor and tax credits for those with substantial medical bills.